Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 355, Issue 26, Pages 2752-2756Publisher
MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMoa063265
Keywords
-
Categories
Ask authors/readers for more resources
Humans have innate immunity against Trypanosoma brucei brucei that is known to involve apolipoprotein L-I (APOL1). Recently, a case of T. evansi infection in a human was identified in India. We investigated whether the APOL1 pathway was involved in this occurrence. The serum of the infected patient was found to have no trypanolytic activity, and the finding was linked to the lack of APOL1, which was due to frameshift mutations in both APOL1 alleles. Trypanolytic activity was restored by the addition of recombinant APOL1. The lack of APOL1 explained the patient's infection with T. evansi.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available